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Post-translational modiﬁcation of membrane proteins (e.g., ion channels, receptors) by
protein kinases is an essential mechanism for control of excitable cell function. Importantly,
loss of temporal and/or spatial control of ion channel post-translational modiﬁcation
is common in congenital and acquired forms of cardiac disease and arrhythmia. The
multifunctional Ca2+/calmodulin-dependent protein kinase II (CaMKII) regulates a number
of diverse cellular functions in heart, including excitation-contraction coupling, gene
transcription, and apoptosis. Dysregulation of CaMKII signaling has been implicated in
human and animal models of disease. Understanding of CaMKII function has been
advanced by mathematical modeling approaches well-suited to the study of complex
biological systems. Early kinetic models of CaMKII function in the brain characterized
this holoenzyme as a bistable molecular switch capable of storing information over a
long period of time. Models of CaMKII activity have been incorporated into models of
the cell and tissue (particularly in the heart) to predict the role of CaMKII in regulating organ
function. Disease models that incorporate CaMKII overexpression clearly demonstrate a
link between its excessive activity and arrhythmias associatedwith congenital and acquired
heart disease. This review aims at discussing systems biology approaches that have been
applied to analyze CaMKII signaling from the single molecule to intact cardiac tissue. In
particular, efforts to use computational biology to provide new insight into cardiac disease
mechanisms are emphasized.
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INTRODUCTION
Signal transduction, whereby a cell receives and processes extra-
cellular information to coordinate a cellular process, is critical for
normal cell function. Signal-transduction systems are commonly
perturbed in disease, making core constituents (e.g., kinases)
attractive therapeutic targets (Levitzki, 2003). While we have
learned a great deal about the components of key signaling path-
ways, the complex nature of these vast networks represents a
signiﬁcant obstacle to understand their dynamics, regulation, and
function. Systems biology and computational modeling of biolog-
ical systems have become increasingly valuable in enhancing our
understanding of these complex protein interaction networks.
Systems biology involves the study of the complex interactions
and associateddynamics found inbiological systems. Systemsbiol-
ogy approaches commonly involve translation of the system into
a mathematical model for subsequent computer simulation and
analysis. As systems-based approaches have gained favor in the
study of human disease processes, so has mathematical modeling
of biological systems with associated advancements in under-
standing complex biological phenomenon like circadian rhythms,
apoptosis, synaptic plasticity, and cell communication (Herzel and
Bluthgen, 2008; Kotaleski and Blackwell, 2010).
The multifunctional Ca2+/calmodulin-dependent protein
kinase II (CaMKII) has emerged as an attractive target for
systems-based approaches that aim to integrate large experi-
mental data with mathematical modeling and computational
approaches across spatial and temporal scales (Figure 1). CaMKII
serves as a nodal point for a vast signaling network that regu-
lates critical processes like learning and memory, cardiomyocyte
contractility, T-cell selection, and expression and localization of
class II MHC molecules in dendritic cells (Braun and Schulman,
1995; Maier and Bers, 2002; McGargill et al., 2005; Herrmann
et al., 2007; Anderson et al., 2011; Swaminathan et al., 2012).
For example, CaMKII regulates multiple important functions in
neurons, including synthesis and release of neurotransmitters,
modulation of ion channel activity, neurite extension, synaptic
plasticity, learning, and gene expression (Braun and Schul-
man, 1995). Similarly, in heart, CaMKII phosphorylates ion
channels, transcription factors, signaling molecules, and other
membrane proteins that are critical to cardiac electrical activity
and structure. Abnormal CaMKII activity has been observed in
human and animal models of cardiovascular disease (e.g., heart
failure, myocardial infarction, arrhythmia), and is thought to pro-
mote downstreamdysfunction in excitation-contraction coupling,
structural remodeling, cell death, and even transcriptional activa-
tion of inﬂammation factors (Maier and Bers, 2002; Swaminathan
et al., 2012). Current research aims at elucidating how this large
effector molecule acts as a pro-cardiac disease/arrhythmogenic
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FIGURE 1 | Multi-scalar mathematical modeling of CaMKII signaling.
(A–D) Mathematical modeling has been applied to understand CaMKII
function across scales from the molecular to the tissue level. Each scale
presents unique challenges and opportunities for modeling efforts.
Abbreviations are as follows: ICa , L-type Ca
2+ current; INa, fast Na+ current;
PLB, phospholamban; IUp , Ca
2+ uptake into the sarcoplasmic reticulum.
molecule and whether it may be effectively targeted for
therapy.
Mathematical modeling studies over the past three decades
have elucidated important aspects of CaMKII function and sig-
naling mechanisms. Pioneering modeling studies focused on
understanding CaMKII structure and function in the brain
(Lisman, 1985; Lisman and Goldring, 1988; Hanson et al., 1994;
Coomber, 1998; Kubota, 1999; Dupont et al., 2003). This
early work motivated later studies that incorporated models
of CaMKII activity into models of the whole cell and tis-
sue (mostly cardiac) to understand the larger role of CaMKII
signaling in cell/organ function (Figure 1; Hund and Rudy,
2004; Iribe et al., 2006; Grandi et al., 2007; Livshitz and Rudy,
2007; Hund et al., 2008; Saucerman and Bers, 2008; Chris-
tensen et al., 2009; Koivumaki et al., 2009; Hashambhoy et al.,
2010; O’Hara et al., 2011). Recently, these efforts have been
expanded to gain insight into the role of CaMKII in human
disease (Hund et al., 2008; Christensen et al., 2009; Koivumaki
et al., 2009; Hashambhoy et al., 2010; Swaminathan et al., 2011;
Lascano et al., 2013; Luo et al., 2013; Zang et al., 2013). This review
aims at describing the challenges, advances and opportunities
for mathematical modeling of CaMKII signaling at each stage
of development across scales from the molecular to the tissue
level.
MODELING THE CAMKII HOLOENZYME
The CaMKII holoenzyme possesses a number of distinguishing
characteristics that pose unique challenges for modeling. Brieﬂy
(details may be found elsewhere (Couchonnal and Anderson,
2008; Anderson et al., 2011; Swaminathan et al., 2012), multi-
ple CaMKII isoforms are expressed in cells with CaMKIIα and
CaMKIIβ expressed predominantly in neurons, whereas CaMKIIγ
andCaMKIIδ aremoreuniformly expressed inother tissues. Struc-
turally, the CaMKII holoenzyme is organized as a hexamer of
dimers arranged as two stacked rings. Each monomer is com-
prised of an N-terminal catalytic domain, a regulatory domain,
and aC-terminal association domain. In its inactive conformation,
the regulatory domain binds to the active site in catalytic domain,
thereby inhibiting the activity of the enzyme. Association of Ca2+
bound calmodulin to the regulatory domain causes its release
from the active site and exposes the active site in catalytic subunit,
enabling the kinase to phosphorylate its substrates (Kolodziej et al.,
2000; Rosenberg et al., 2005). Multiple residues within the regula-
tory domain are also exposed thatmay subsequently undergo post-
translational regulation (e.g., phosphorylation, oxidation, glyco-
sylation) that, in turn, alter kinase function (Lai et al., 1986; Braun
and Schulman, 1995; Erickson et al., 2008; Swaminathan et al.,
2012; Erickson et al., 2013). Enzyme regulation/activity depends
heavily on the multimeric holoenzyme structure (Kolodziej et al.,
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2000; Hoelz et al., 2003; Rellos et al., 2010; Chao et al., 2011;
Stratton et al., 2013). For example, a distinguishing character-
istic is the ability of CaMKII to undergo autophosphorylation
where an active (Ca2+/calmodulin bound) kinase subunit is
phosphorylated at a speciﬁc residue (Thr286/287) by a neigh-
boring active subunit (Lai et al., 1986; Braun and Schulman,
1995). The autophosphorylated kinase retains activity in the
absence of bound Ca2+/calmodulin and is thought to con-
tribute to synaptic plasticity and learning functions as well as
myocyte excitation-contraction coupling (Silva et al., 1992a,b;
Dupont et al., 2003).
One of the most obvious and compelling challenges for
modeling of CaMKII is autoregulation. The simplest models
consider the entire population of CaMKII subunits that are sub-
ject to autophosphorylation at a rate dependent on levels of
Ca2+/calmodulin (Hanson et al., 1994; Dupont et al., 2003; Gaert-
ner et al., 2004; Chiba et al., 2008). Detailed models have also been
developed that incorporate structural information to account for
the fact that CaMKII autophophosphorylation is constrained by
physical proximity of active subunits (Lisman and Goldring, 1988;
Michelson and Schulman, 1994; Zhabotinsky, 2000; Kubota and
Bower, 2001;Miller et al., 2005; Lucic et al., 2008;Michalski, 2013).
Recently, efforts have been made to also account for other kinase
activationmodes (e.g., oxidation; Christensen et al., 2009).Model-
ing studies at themolecular level have generated important insight
into CaMKII function. In particular, models have been used to
demonstrate that CaMKII activity is sensitive to changes in Ca2+
spike frequency and is capable of long-term storage of informa-
tion at the post-synaptic density by acting as a bistable switch
(Lisman, 1985; Lisman and Goldring, 1988; Hanson et al., 1994;
Coomber, 1998; Kubota, 1999; Dupont et al., 2003). Furthermore,
modeling studies have demonstrated the importance of autophos-
phorylation for bistability in CaMKII signaling, although there
is some debate about the requisite conditions and physiological
relevance (Zhabotinsky, 2000; Michalski, 2013). Together, these
initial CaMKII modeling studies provided important insight into
the link between holoenzyme structure, the ability of the kinase
to encode Ca2+spike information, and behavior (e.g., long-term
potentiation) in neurons. Moreover, this work laid the essential
foundation for subsequent multi-scale studies in other systems
(e.g., heart).
MODELING CAMKII SIGNALING IN THE INTACT CELL AND
TISSUE
Much work has been done, particularly in the cardiac ﬁeld, to
incorporate models of the CaMKII signaling pathway into models
of the intact cell (Figure 2). Modeling of CaMKII signaling at the
cellular level poses a unique set of challenges in addition to those
encountered at the molecular level (Table 1). First, the kinase is
sensitive to intracellular Ca2+, whose temporal and spatial proﬁle
is tightly controlled. In the myocyte, for example, inﬂux of Ca2+
through voltage-gated Ca2+ channels during the action poten-
tial (AP) triggers Ca2+ release from the sarcoplasmic reticulum
(SR) that leads to a large increase in intracellular Ca2+(free and
calmodulin-bound) levels. Thus, any cellmodel of the kinase path-
way must address the dynamic nature of the input, namely Ca2+-
bound calmodulin. Second, once activated, the multifunctional
kinase targets a large number of substrates in the cell, from
membrane ion channels, pumps and transporters to contractile
proteins and even transcription factors. Onemust consider a priori
which targets are likely important for the phenomenon of interest.
Finally, CaMKII interacts with a vast and complex signaling web
that includes other proteins directly regulated byCa2+/calmodulin
(e.g., ion channels, calcineurin), protein phosphatases that
antagonize CaMKII phosphorylation (e.g., PP1), and other
kinases that potentially synergize CaMKII effects (e.g., protein
kinase A).
Despite these numerous obstacles, CaMKII signaling networks
have been successfully incorporated with varying degrees of com-
plexity into whole cell models of the myocyte (mostly ventricular)
action potential and calcium transient (Hund and Rudy, 2004;
Iribe et al., 2006; Grandi et al., 2007; Livshitz and Rudy, 2007;
Hund et al., 2008; Saucerman and Bers, 2008; Christensen et al.,
2009; Koivumaki et al., 2009; Hashambhoy et al., 2010; O’Hara
et al., 2011), as well as other non-cardiac cell types (Dupont
et al., 2010; Mironov, 2013). These models have employed dif-
ferent strategies to deal with challenges outlined above. The
most common class of models incorporate a scheme where a
single population of CaMKII responds to changes in bulk or sub-
space Ca2+/calmodulin (Hund and Rudy, 2004; Iribe et al., 2006;
Livshitz and Rudy, 2007; Hund et al., 2008). In other cases, a
static formalism is adopted where CaMKII-dependent effects on
membrane substrates are implemented in the absence of dynamic
changes in CaMKII activity (Grandi et al., 2007; Thiel et al., 2008;
Koval et al., 2010; Koval et al., 2012). More recently, considera-
tion has been given to compartmentalization of CaMKII signaling
within the cell (Saucerman and Bers, 2008; Song et al., 2008; Soltis
and Saucerman, 2010). In general, models account for CaMKII-
dependent effects on membrane ion channels and transporters
important for Ca2+ cycling, including the ryanodine receptor
(RyR), SERCA 2a (SR Ca2+ ATPase), phospholamban (PLB), and
L-type Ca2+ channels. As data have emerged regarding CaMKII-
dependent effects on other channels important for the action
potential (e.g., INa and Ito), these effects have also been incor-
porated (Grandi et al., 2007; Hund et al., 2008; Christensen et al.,
2009; Hashambhoy et al., 2010; Koval et al., 2012). It is expected
that as we learn more about the speciﬁc molecular targets for
CaMKII within the cell, models will adapt to account for the new
ﬁndings.
What have we learned from cellular models of CaMKII signal-
ing? Several computational studies have demonstrated the ability
of CaMKII to regulate myocyte action potential, Ca2+ transient,
and even contractile force in a rate-dependent manner (Hund and
Rudy, 2004; Iribe et al., 2006; Livshitz and Rudy, 2007; Soltis and
Saucerman, 2010; O’Hara et al., 2011). Interestingly, a role for
CaMKII has emerged not only in normal rate dependent behavior
(e.g., AP duration adaptation and force-frequency relationships),
but also in promoting cellular triggers for arrhythmias such as AP
alternans and afterdepolarizations (Grandi et al., 2007; Livshitz
and Rudy, 2007; Thiel et al., 2008; Hashambhoy et al., 2010; Koval
et al., 2010; Soltis and Saucerman, 2010). Integrated myocyte
models have also been applied to increase our understanding of
spatial and temporal control of CaMKII signaling (Saucerman
and Bers, 2008; Song et al., 2008; Soltis and Saucerman, 2010).
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FIGURE 2 | Mathematical modeling of CaMKII signaling in the intact
cell. (A) Schematic of the Hund-Rudy model of the ventricular action
potential that accounts for dynamic CaMKII signaling (Christensen et al.,
2009). Abbreviations are as follows: INa , fast Na
+ current; INa,L , late
(persistent) Na+ current; ICa(L), L-type Ca2+ current; INaCa , Na+/Ca2+
exchanger; Ip(Ca), sarcolemmal Ca
2+ pump; ICa,b , background Ca2+
current; ICl ,b , background Cl
− current; CTNaCl , Na+/Cl−cotransporter;
CTKCl , K
+/Cl−cotransporter; Ito1, transient outward K+ current; Ito2,
Ca2+-dependent transient outward current; IKr , rapid delayed rectiﬁer K+
current; IKs , slow delayed rectiﬁer K
+ current; IK1, inward rectiﬁer K+
current; IKp , plateau K
+ current; INaK , Na+/K+ ATPase; IK (Na),
Na+-dependent K+ current; IK (ATP), ATP-sensitive K+ current; Irel ,
sarcoplasmic reticulum (SR) ryanodine receptor Ca2+ release channel;
IUp , SR Ca
2+ pump; PLB, phospholamban; Ileak , SR Ca2+ leak; NSR,
network SR; JSR, junctional SR; Itr , Ca2+ transfer from NSR to JSR.
(B) State diagram for integrated CaMKII model that includes inactive (I),
Ca2+/calmodulin bound (B), autophosphorylated (P, OxP) and oxidized
active states (Ox, OxP). Abbreviations are as follows: kIB , kBI , forward
and reverse rate constants, respectively, for transition from inactive state
to Ca2+/calmodulin bound state; kA , kPB , autophosphorylation and
dephosphorylation rate constants, respectively, for transition from
Ca2+/calmodulin bound state to autophosphorylated state; kA , kOxPOx ,
autophosphorylation and dephosphorylation rate constants, respectively,
for transition from oxidized active state to oxidized and
autophosphorylated state; kOxB , kBOx , forward and reverse rate
constants, respectively, for transition fromCa2+/calmodulin bound state to
oxidized active state; kPOxP , kOxPP , forward and reverse rate constants,
respectively, for transition from autophosphorylated state to oxidized and
autophosphorylated active state. Simulated (C) action potentials and
(D) CaMKII activity from the model at two different pacing frequencies to
demonstrate sensitivity of CaMKII to pacing frequency.
Interestingly, studies in this area have demonstrated the impor-
tance of afﬁnity for Ca2+/calmodulin in deﬁning the differential
response of CaMKII and the protein phosphatase calcineurin to
the dynamic Ca2+ transient (Saucerman and Bers, 2008; Song
et al., 2008). Furthermore, studies that incorporate both CaMKII
and PKA signaling have shown how the two networks synergize
for joint regulation of excitation-contraction coupling (Soltis and
Saucerman, 2010). It will be interesting, going forward, to model
how other factors such as interaction with scaffolding/anchoring
proteins (e.g., βIV-spectrin) may contribute to spatial control of
CaMKII signaling (Hund et al., 2010; Koval et al., 2010), similar
to studies involving other signaling networks (Chan et al., 2012;
Greenwald et al., 2014). Finally, although considerable less work
has been done in this area compared to smaller scales, progress
has been made to understand the role of CaMKII in coordinating
function at the tissue/organ level (Livshitz and Rudy, 2007; Chris-
tensen et al., 2009; Swaminathan et al., 2011; Luo et al., 2013).
These multicellular studies have identiﬁed roles for CaMKII in
regulating AP heterogeneity and conduction, as well as cardiac
pacemaking.
MODELING CAMKII SIGNALING IN DISEASE
CaMKII plays a critical role in regulating the substrate for
both electrical and mechanical dysfunction in cardiovascular dis-
ease (Anderson et al., 2011; Swaminathan et al., 2012). Perhaps
the greatest challenge for mathematical modeling of CaMKII
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Table 1 | Challenges for modeling of CaMKII activity across scales from molecule to tissue.
Scale Challenges for modeling Representative models
Molecule Regulation by Ca2+/calmodulin and post-translational
modiﬁcation (including autophosphorylation).
Hanson et al. (1994), Coomber (1998), Dupont et al. (2003), Gaertner et al. (2004).
Complex structure/function relationship. Lisman and Goldring (1988), Michelson and Schulman (1994), Zhabotinsky (2000),
Kubota and Bower (2001), Miller et al. (2005), Lucic et al. (2008), Michalski (2013).
Cell Dynamic Ca2+ signaling as input.
Large number of substrates.
Resides at center of vast signaling network.
Hund and Rudy (2004), Iribe et al. (2006), Grandi et al. (2007), Livshitz and Rudy
(2007), Chiba et al. (2008), Saucerman and Bers (2008), Soltis and Saucerman
(2010), Dupont et al. (2010), O’Hara et al. (2011).
Chronic vs. acute effects of CaMKII activation. Hund et al. (2008), Koivumaki et al. (2009), Hashambhoy et al. (2010), Lascano
et al. (2013), Zang et al. (2013).
Tissue/organ Chronic and acute remodeling in disease. Christensen et al., 2009, Swaminathan et al., 2012, Luo et al., 2013.
signaling is how to ultimately link function at the molecular
level to behavior at cell/tissue level in the setting of disease.
Among the difﬁculties for modeling in this area involves distin-
guishing between acute and chronic effects of CaMKII activity.
For example, while acute effects of CaMKII are mostly medi-
ated by posttranslational modiﬁcation of substrates, chronic
CaMKII activation may facilitate large scale remodeling changes
due to effects on transcription and gene expression (Koivumaki
et al., 2009; Swaminathan et al., 2012). Mathematical model-
ing and computer simulation have been used to generate new
insights into molecular mechanisms for arrhythmia in several
disease states, including myocardial ischemia/infarction, heart
failure, and diabetes (Hund et al., 2008; Christensen et al., 2009;
Swaminathan et al., 2011; Lascano et al., 2013; Luo et al., 2013;
Zang et al., 2013).
Arrhythmiamechanisms in the canine infarct border zone have
been studied extensively using amathematical modeling approach
(Cabo and Boyden, 2003; Cabo et al., 2006; Hund et al., 2008;
Christensen et al., 2009). The canine infarct border zone is par-
ticularly well suited to mathematical modeling approach due to
the tremendous amount of available data at the molecular, cel-
lular, and tissue level (Pinto and Boyden, 1999). Mathematical
models have been used to link defects in CaMKII signaling with
ion channel remodeling, abnormal Ca2+ handling, and arrhyth-
mias in the infarct border zone. Speciﬁcally these studies have
demonstrated that increased autophosphorylation and oxidation
of the kinase results in increased activity that both increases Ca2+
leak from the sarcoplasmic reticulum and compromises availabil-
ity of voltagegated Na+ channels to create a favorable substrate
for arrhythmias (Hund et al., 2008; Christensen et al., 2009). More
recently, mathematical models have been used to study the role of
chronic CaMKII activation in sinus node dysfunction in the set-
ting of heart failure and diabetes (Swaminathan et al., 2011; Luo
et al., 2013). A two dimensional model of the intact sinus node
has been applied to demonstrate that CaMKII-induced apoptosis
and associated loss of sinoatrial node cells disrupts the source–
sink balance between the sinoatrial node and surrounding atrial
myocardium resulting in slowed pacemaking and even failure
(Swaminathan et al., 2011; Luo et al., 2013). Other studies have
used mathematical modeling to determine relative importance of
direct CaMKII effects and compensatory changes in gene regula-
tion in the setting of chronic CaMKII overexpression (Koivumaki
et al., 2009). Finally, in addition to common forms of acquired
disease (e.g., myocardial infarction, heart failure, diabetes), math-
ematical models have been used to better understand the role
of CaMKII in congenital disease (Thiel et al., 2008; Koval et al.,
2012). A recent study usedmathematicalmodeling to demonstrate
that human variants identiﬁed in the CaMKII phosphorylation
motif of Nav1.5 confer arrhythmia susceptibility by mimicking
the phosphorylated channel (Koval et al., 2012), while an ear-
lier study examined the role of CaMKII regulation of SR Ca2+
release in increased incidence of afterdepolarizations in Timothy
syndrome (Thiel et al., 2008). Together these studies demonstrate
the potential for mathematical modeling and computer simula-
tion in advancing our understanding of CaMKII biology and its
role over a broad range of cardiovascular disease.
FUTURE DIRECTIONS
This reviewhas outlined themany unique challenges and opportu-
nities for multiscale mathematical modeling of CaMKII signaling.
While great strides have been made in development and applica-
tion of mathematical models of CaMKII signaling from molecule
to tissue, clearly there are outstanding issues and unanswered
questions to be addressed by future research in this area. At the
molecular level, the recent discovery of the CaMKII crystal struc-
ture represents an exciting development with great potential for
modeling (Chao et al., 2011). Similarly, it will be important for
future modeling efforts to address novel pathways for regulation
of CaMKII activity (e.g., glycosylation). At the cell level, a daunting
challenge remains the sheer number of targets for CaMKII within
the cell, with new substrates identiﬁed every year. Moreover, it
remains to be understood the “tipping point” from the adaptive to
the maladaptive aspects of CaMKII signaling. Finally, while most
models have focusedon the ventricularmyocyte as a system, clearly
CaMKII has important roles in other heart regions/cell types (e.g.,
atrial, sinoatrial node cells). Models of these different cell types
that incorporate cell-speciﬁc CaMKII signaling will be of great use
for studying CaMKII signaling at the organ level.
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